HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1

Journal of Cardiac Failure

Volumn 23, Issue 4, 2017, Pages 293-303

  Faxén, Ulrika Ljung ^a,b   Hage, Camilla ^a,b   Benson, Lina ^b   Zabarovskaja, Stanislava ^a,b   Andreasson, Anna ^b,c   Donal, Erwan ^d   Daubert, Jean Claude ^d   Linde, Cecilia ^a,b   Brismar, Kerstin ^a,b   Lund, Lars H ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

biomarker; heart failure with preserved ejection fraction; insulin like growth factor 1; insulin like growth factor binding protein 1

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; BIOLOGICAL MARKER; GROWTH HORMONE;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; CLINICAL TRIAL; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; STATISTICS; SWEDEN;

AGED; BIOMARKERS; FEMALE; GROWTH HORMONE; HEART FAILURE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MALE; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; STATISTICS AS TOPIC; STROKE VOLUME; SWEDEN; VENTRICULAR FUNCTION, LEFT;

EID: 84997834626     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2016.06.008     Document Type: Article

References (30)

1. 1 Butler, J., Fonarow, G.C., Zile, M.R., Lam, C.S., Roessig, L., Schelbert, E.B., et al. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail 2 (2014), 97–112.
2. 2 Sacca, L., Heart failure as a multiple hormonal deficiency syndrome. Circ Heart Fail 2 (2009), 151–156.
3. 3 Lund, L.H., Freda, P., Williams, J.J., LaManca, J.J., LeJemtel, T.H., Mancini, D.M., Growth hormone resistance in severe heart failure resolves after cardiac transplantation. Eur J Heart Fail 11 (2009), 525–528.
4. 4 Bach, L.A., Endothelial cells and the IGF system. J Mol Endocrinol 54 (2015), R1–13.
5. 5 Arcopinto, M., Bobbio, E., Bossone, E., Perrone-Filardi, P., Napoli, R., Sacca, L., et al. The GH/IGF-1 axis in chronic heart failure. Endocr Metab Immune Disord Drug Targets 13 (2013), 76–91.
6. 6 Baxter, R.C., Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278 (2000), E967–76.
7. 7 Unden, A.L., Elofsson, S., Brismar, K., Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study. Clin Endocrinol (Oxf) 63 (2005), 94–102.
8. 8 Al-Obaidi, M.K., Hon, J.K., Stubbs, P.J., Barnes, J., Amersey, R.A., Dahdal, M., et al. Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failure. Am Heart J, 142, 2001, E10.
9. 9 Arcopinto, M., Isgaard, J., Marra, A.M., Formisano, P., Bossone, E., Vriz, O., et al. IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry. Int J Cardiol 176 (2014), 1006–1008.
10. 10 Jankowska, E.A., Biel, B., Majda, J., Szklarska, A., Lopuszanska, M., Medras, M., et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 114 (2006), 1829–1837.
11. 11 Saeki, H., Hamada, M., Hiwada, K., Circulating levels of insulin-like growth factor-1 and its binding proteins in patients with hypertrophic cardiomyopathy. Circ J 66 (2002), 639–644.
12. 12 Donal, E., Lund, L.H., Linde, C., Edner, M., Lafitte, S., Persson, H., et al. Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction. Eur J Heart Fail 11 (2009), 198–204.
13. 13 Bang, P., Eriksson, U., Sara, V., Wivall, I.L., Hall, K., Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol 124 (1991), 620–629.
14. 14 Hilding, A., Hall, K., Wivall-Helleryd, I.L., Saaf, M., Melin, A.L., Thoren, M., Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19–82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 84 (1999), 2013–2019.
15. 15 Povoa, G., Roovete, A., Hall, K., Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol 107 (1984), 563–570.
16. 16 Soderberg, S., Ahren, B., Eliasson, M., Dinesen, B., Brismar, K., Olsson, T., Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women. Eur J Endocrinol 144 (2001), 283–290.
17. 17 Hall, K., Hilding, A., Thoren, M., Determinants of circulating insulin-like growth factor-I. J Endocrinol Invest 22:5 Suppl (1999), 48–57.
18. 18 Wheatcroft, S.B., Kearney, M.T., IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends Endocrinol Metab 20 (2009), 153–162.
19. 19 Fernqvist-Forbes, E., Hilding, A., Ekberg, K., Brismar, K., Influence of circulating epinephrine and norepinephrine on insulin-like growth factor binding protein-1 in humans. J Clin Endocrinol Metab 82 (1997), 2677–2680.
20. 20 Catrina, S.B., Rotarus, R., Botusan, I.R., Coculescu, M., Brismar, K., Desmopressin increases IGF-binding protein-1 in humans. Eur J Endocrinol 158 (2008), 479–482.
21. 21 Lang, C.H., Nystrom, G.J., Frost, R.A., Regulation of IGF binding protein-1 in hep G2 cells by cytokines and reactive oxygen species. Am J Physiol 276:3 Pt 1 (1999), G719–27.
22. 22 Paulus, W.J., Tschope, C., A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62 (2013), 263–271.
23. 23 Kaplan, R.C., McGinn, A.P., Pollak, M.N., Kuller, L., Strickler, H.D., Rohan, T.E., et al. High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly. Am Heart J 155 (2008), 1006–1012.
24. 24 Lee, P.D., Giudice, L.C., Conover, C.A., Powell, D.R., Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 216 (1997), 319–357.
25. 25 Hong, Y., Brismar, K., Hall, K., Pedersen, N.L., de Faire, U., Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: results from middle-aged and elderly monozygotic twins. J Endocrinol 153 (1997), 251–257.
26. 26 Hilding, A., Brismar, K., Degerblad, M., Thoren, M., Hall, K., Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 80 (1995), 2646–2652.
27. 27 Meirovich, Y.F., Veinot, J.P., de Bold, M.L., Haddad, H., Davies, R.A., Masters, R.G., et al. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant 27 (2008), 31–37.
28. 28 Ramos, H.R., Birkenfeld, A.L., de Bold, A.J., Interacting disciplines: cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist. Endocr Connect 4 (2015), R25–36.
29. 29 Niebauer, J., Pflaum, C.D., Clark, A.L., Strasburger, C.J., Hooper, J., Poole-Wilson, P.A., et al. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 32 (1998), 393–397.
30. 30 Isgaard, J., Arcopinto, M., Karason, K., Cittadini, A., GH and the cardiovascular system: an update on a topic at heart. Endocrine 48 (2015), 25–35.